中青年急性心肌梗死患者血清IGFBP5、sOSCAR水平及其与冠状动脉狭窄程度和预后的关系OA
Expression of IGFBP5 and sOSCAR in peripheral blood of young and middle-aged patients with acute myocardial in-farction and the relationship with the degree of coronary stenosis and prognosis
目的 探讨中青年急性心肌梗死(AMI)患者血清胰岛素样生长因子结合蛋白5(IGFBP5)、可溶性破骨细胞相关受体(sOSCAR)水平及其临床意义.方法 前瞻性选取2021年1月—2023年6月邢台市中心医院心内科收治的中青年AMI患者105例作为AMI组,根据冠状动脉狭窄程度(Gensini评分)分为轻度狭窄(<30分)32例、中度狭窄(30~60分)42例、重度狭窄(>60分)31例,再根据24个月预后将中青年AMI患者分为不良亚组42例和良好亚组63例,另选取同期医院健康体检志愿者60例为健康对照组.采用酶联免疫吸附法检测血清IGFBP5、sOSCAR水平;Pearson相关系数分析血清IGFBP5、sOSCAR水平与Gensini评分的相关性;多因素Logistic回归分析中青年AMI患者经皮冠状动脉介入治疗(PCI)术后预后不良的影响因素;受试者工作特征(ROC)曲线分析血清IGFBP5、sOSCAR水平对中青年AMI患者PCI术后预后不良的预测效能.结果 与健康对照组比较,AMI组血清IGFBP5水平升高,sOSCAR水平降低(t/P=15.073/<0.001、16.141/<0.001);轻度狭窄、中度狭窄、重度狭窄中青年AMI患者血清IGFBP5水平依次升高,sOSCAR水平依次降低(F/P=268.737/<0.001、87.294/<0.001);Pearson相关性分析显示,中青年AMI患者血清IGFBP5水平与Gensini评分呈正相关(r/P=0.745/<0.001),血清sOSCAR水平与Gensini评分呈负相关(r/P=-0.732/<0.001);KILLIP分级≥ Ⅱ级、Gensini评分高、血清IGFBP5水平高是中青年AMI患者PCI术后预后不良的独立危险因素[OR(95%CI)=2.754(1.141~6.647)、3.636(1.518~8.710)、1.013(1.005~1.021)],血清 sOSCAR 水平升高为独立保护因素[OR(95%CI)=0.987(0.987~0.997)];血清IGFBP5、sOSCAR水平单独及二者联合预测中青年AMI患者PCI术后预后不良的AUC分别为0.782、0.785、0.856,二者联合优于各自单独预测效能(Z/P=2.141/0.032、2.348/0.019).结论 中青年AMI患者血清IGFBP5水平升高、sOSCAR水平降低,且与冠状动脉狭窄程度加重和预后不良密切相关,血清IGFBP5、sOSCAR水平联合预测中青年AMI患者PCI术后预后不良的价值较高.
Objective To investigate the expression and clinical significance of serum insulin-like growth factor binding protein 5(IGFBP5)and soluble osteoclast-associated receptor(sOSCAR)in young and middle-aged patients with acute myocardial infarction(AMI).Methods A total of 105 young and middle-aged AMI patients admitted to the Department of Cardiology,Xingtai Central Hospital from January 2021 to June 2023 were prospectively selected as the AMI group.According to the degree of coronary stenosis(Gensini score),they were divided into mild stenosis(<30 points,32 ca-ses),moderate stenosis(30-60 points,42 cases),and severe stenosis(>60 points,31 cases).Additionally,60 healthy volunteers were selected as the healthy control group.The young and middle-aged AMI patients were further divided into poor and good prognosis subgroups based on their 24-month prognosis.Serum IGFBP5 and sOSCAR expression levels were detec-ted by enzyme-linked immunosorbent assay.Pearson correlation analysis was used to analyze the correlation between serum IGFBP5,sOSCAR expression,and Gensini score.The relationship between serum IGFBP5 and sOSCAR expression and the prognosis of young and middle-aged AMI patients,as well as their predictive efficacy,were analyzed.Results Compared with the healthy control group,serum IGFBP5 expression was increased and sOSCAR expression was decreased in the AMI group(t/P=15.073/<0.001,16.141/<0.001).Serum IGFBP5 expression increased sequentially,and sOSCAR expression de-creased sequentially,across mild,moderate,and severe stenosis groups(F/P=268.737/<0.001,87.294/<0.001).In young and middle-aged AMI patients,Gensini score was positively correlated with serum IGFBP5 expression and negatively correlated with sOSCAR expression(r/P=0.745/<0.001,-0.732/<0.001).The 12-month poor prognosis rate among the 105 young and middle-aged AMI patients was 40.00%(42/105).Gensini score,Killip grade ≥ Ⅱ,and elevated IGFBP5 were independent risk factors for poor prognosis,while elevated sOSCAR was an independent protective factor[OR(95%CI)=3.636(1.518-8.710),2.754(1.141-6.647),1.013(1.005-1.021),0.987(0.987-0.997)].The AUCs of serum IGFBP5 expression,sOSCAR expression,and their combination for predicting poor prognosis in young and middle-aged AMI patients were 0.784,0.786,and 0.857,respectively.The combined prediction showed a larger AUC(Z/P=2.141/0.032,2.348/0.019).Conclusion Serum IGFBP5 expression is increased and sOSCAR expression is decreased in young and middle-aged AMI patients,which is close-ly related to the aggravation of coronary stenosis and poor prognosis.The combined detection of serum IGFBP5 and sOSCAR has higher predictive efficacy for poor prognosis in young and middle-aged AMI patients.
史苏娜;白敬淼;蔺晓娟;董梅;郭子力;李振莲
054000 河北省邢台市中心医院心内科054000 河北省邢台市中心医院彩超室054000 河北省邢台市中心医院检验科054000 河北省邢台市中心医院心内科054000 河北省邢台市中心医院心内科054000 河北省邢台市中心医院心内科
医药卫生
急性心肌梗死胰岛素样生长因子结合蛋白5可溶性破骨细胞相关受体冠状动脉狭窄程度预后中青年
Acute myocardial infarctionInsulin-like growth factor binding protein 5Soluble osteoclast-associated re-ceptorCoronary artery stenosisPrognosisYoung and middle-aged
《疑难病杂志》 2026 (1)
19-24,6
河北省医学科学研究课题计划项目(20220312) Hebei Medical Science Research Project(20220312)
评论